US FDA’s Advanced Manufacturing Designation Lifts Off With Cellares Cell Shuttle

Cellares’ fully automated cell therapy manufacturing platform is the first system to receive an Advanced Manufacturing Technology designation from US FDA

Cellares hopes its Cell Shuttle will ride an Advanced Manufacturing Technology designation to new corporate heights (Shutterstock)

More from Platform Technologies

More from Compliance